Rybelsus 3 mg (Semaglutide)

Description

Introduction

Rybelsus 3 mg is an oral tablet containing semaglutide. It is used in the treatment of type 2 diabetes as part of a broader plan that includes diet and exercise. This description explains the tablet’s role, how it works and the main safety considerations.

The 3 mg strength is used at the beginning of treatment. It is not a maintenance strength. A healthcare professional determines whether treatment is appropriate and what happens after the initial period.

What Is It?

Rybelsus is a prescription medicine in the glucagon-like peptide-1 (GLP-1) receptor agonist class. Each 3 mg tablet contains 3 mg of semaglutide and is taken by mouth. This tablet formulation differs from injectable semaglutide products; the products and their doses should not be substituted without professional guidance.

Type 2 diabetes is a condition in which blood glucose remains too high because the body does not produce enough insulin, does not respond effectively to it, or both. Rybelsus is one treatment option when blood glucose is insufficiently controlled with diet and exercise.

How Does It Work?

Semaglutide acts on GLP-1 receptors. When blood glucose is high, it helps the pancreas release insulin and reduces the release of glucagon, a hormone that raises blood glucose. It also slows stomach emptying. These actions can help improve blood glucose control over the course of treatment.

Its effect on insulin release depends on blood glucose levels. Low blood glucose can still occur, particularly when Rybelsus is used with insulin or a sulfonylurea.

Common Uses

Rybelsus is used for adults with type 2 diabetes whose blood glucose is not adequately controlled with diet and exercise. It may be used alone when metformin is inappropriate because of intolerance or a contraindication, or alongside other medicines for type 2 diabetes.

The 3 mg tablet serves as an initial treatment strength. It should not be presented as a stand-alone maintenance treatment. Rybelsus is not used to treat type 1 diabetes or diabetic ketoacidosis. Weight management is not the stated indication for this product.

Available Strengths

• Rybelsus 3 mg (Semaglutide)
• Rybelsus 7 mg (Semaglutide)
• Rybelsus 14 mg (Semaglutide)

Key Features

• Contains 3 mg semaglutide in an oral tablet.
• Belongs to the GLP-1 receptor agonist medicine class.
• Used as an initial strength in type 2 diabetes treatment.
• Can be part of treatment alongside diet, exercise and, where appropriate, other diabetes medicines.
• Its absorption depends on how the tablet is taken in relation to food, drinks and other oral medicines.

Benefits

• Semaglutide can improve blood glucose control in adults with type 2 diabetes when used as part of an appropriate treatment plan.
• The tablet provides an oral formulation of semaglutide.
• The 3 mg strength allows treatment to begin before a healthcare professional assesses the move to a maintenance strength.
• Rybelsus may be used with other glucose-lowering medicines when clinically appropriate.

The response to treatment varies. The 3 mg strength is intended for treatment initiation rather than ongoing blood glucose control on its own.

Possible Side Effects

• Nausea, diarrhoea and vomiting are among the most commonly reported effects.
• Other possible effects include abdominal pain, constipation, indigestion, reflux and reduced appetite.
• Low blood glucose is more likely when Rybelsus is combined with insulin or a sulfonylurea.
• Vomiting or diarrhoea can cause dehydration and, in rare cases, worsen kidney function.
• Severe, persistent abdominal pain may be a sign of pancreatitis and needs prompt medical assessment.
• A serious allergic reaction requires urgent medical attention.

This is not a complete list of possible side effects. A healthcare professional can help assess symptoms that are new, severe or do not settle.

Precautions

• Discuss any history of pancreatitis before treatment, as caution is needed.
• People with diabetic retinopathy may need monitoring. Rapid improvement in blood glucose control can be associated with temporary worsening of retinopathy.
• Tell a healthcare professional about kidney problems, especially if nausea, vomiting or diarrhoea causes fluid loss.
• Rybelsus should not be used during pregnancy. Discuss pregnancy or pregnancy plans with a healthcare professional.
• Tell the prescriber about any previous allergic reaction to semaglutide or another ingredient in the tablet.

Additional Precautions

• Rybelsus is not a treatment for type 1 diabetes or diabetic ketoacidosis.
• Its safety and effectiveness in people under 18 years of age have not been established.
• Blood glucose monitoring may be particularly important when insulin or a sulfonylurea is also used.
• Discuss breastfeeding with a healthcare professional; semaglutide should not be used during breastfeeding.
• Do not substitute an injectable semaglutide product or a different tablet strength without professional guidance.

Storage Instructions

• Store the tablets below 30°C.
• Keep them in the original blister package to protect them from moisture and light.
• Check the expiry date on the packaging before use.
• Keep medicines out of the sight and reach of children.
• Ask a pharmacist how to dispose of unused or expired tablets.

How to Take

• Rybelsus is an oral tablet. Follow the directions supplied with the prescription for the prescribed strength.
• It is taken on an empty stomach and swallowed whole with a small amount of water. Do not split, crush or chew the tablet.
• Food, drinks and other oral medicines taken too soon afterwards can reduce semaglutide absorption. The product information specifies a waiting period of at least 30 minutes.
• A healthcare professional determines the treatment schedule and any change from the 3 mg initial strength.
• If a dose is missed or the directions are unclear, check the medicine information or ask a pharmacist for guidance.

Drug Interactions

• Insulin and sulfonylureas can increase the risk of low blood glucose when used with Rybelsus.
• Semaglutide slows stomach emptying, which may affect the absorption of some oral medicines.
• Levothyroxine exposure may increase when taken with oral semaglutide; thyroid monitoring may be considered.
• People taking warfarin or another coumarin anticoagulant may need closer INR monitoring when semaglutide treatment begins.
• Taking other oral tablets at the same time can reduce semaglutide absorption.

Give a healthcare professional a current list of prescription medicines, non-prescription medicines and supplements so potential interactions can be reviewed.

Why Choose This Product?

• It is a 3 mg oral semaglutide tablet for the initial phase of type 2 diabetes treatment.
• Semaglutide has an established blood glucose-lowering action through GLP-1 receptors.
• The tablet formulation provides an oral treatment option.
• Its use can be assessed alongside diet, exercise and other diabetes medicines within an individual treatment plan.

Frequently Asked Questions (FAQs)

What is the active ingredient?

Each Rybelsus 3 mg tablet contains 3 mg of semaglutide.

Is Rybelsus an injection?

No. This product is a tablet taken by mouth. Injectable semaglutide products have different formulations.

What condition is it used for?

It is used to treat adults with insufficiently controlled type 2 diabetes alongside diet and exercise.

Is 3 mg a maintenance strength?

No. The 3 mg strength is used to begin treatment. A healthcare professional decides whether and when treatment changes.

Can it be used with other diabetes medicines?

Yes, it may be used with other medicines for type 2 diabetes when clinically appropriate. Some combinations increase the risk of low blood glucose.

Can it be taken with food?

Food can reduce semaglutide absorption. Follow the medicine information and the directions provided with the prescription.

What side effects are most common?

Nausea, diarrhoea and vomiting are among the most commonly reported side effects.

Is it a weight-loss medicine?

Weight change may occur, but this product’s stated indication is treatment of type 2 diabetes.

Can it be used during pregnancy?

Rybelsus should not be used during pregnancy. Discuss pregnancy or plans to become pregnant with a healthcare professional.

How should the tablets be stored?

Store them below 30°C in their original blister package, protected from moisture and light.